These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis. Gertosio C; Licari A; De Silvestri A; Rebuffi C; Chiappini E; Marseglia GL Vaccine; 2022 Apr; 40(19):2679-2695. PubMed ID: 35370019 [TBL] [Abstract][Full Text] [Related]
26. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age. Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613 [TBL] [Abstract][Full Text] [Related]
29. Serologic evaluation of vaccine preventable infections and vaccination rates in kidney transplant candidates. Schneider S; Carlson A; Sirandas B; Clark B; Truax C Transpl Infect Dis; 2022 Dec; 24(6):e13973. PubMed ID: 36263508 [TBL] [Abstract][Full Text] [Related]
30. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Nolan T; McIntyre P; Roberton D; Descamps D Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial. Lalwani S; Chatterjee S; Balasubramanian S; Bavdekar A; Mehta S; Datta S; Povey M; Henry O BMJ Open; 2015 Sep; 5(9):e007202. PubMed ID: 26362659 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review. Keller M; Pittet LF; Zimmermann P Eur J Pediatr; 2022 Apr; 181(4):1329-1362. PubMed ID: 34936010 [TBL] [Abstract][Full Text] [Related]
33. Vaccination for Children on Biologics. Toplak N; Uziel Y Curr Rheumatol Rep; 2020 May; 22(7):26. PubMed ID: 32436130 [TBL] [Abstract][Full Text] [Related]
34. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL J Can Assoc Gastroenterol; 2021 Aug; 4(4):e59-e71. PubMed ID: 34476338 [TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
36. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Wellington K; Goa KL Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients. Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961 [TBL] [Abstract][Full Text] [Related]
38. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents. Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990 [TBL] [Abstract][Full Text] [Related]
39. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. Daien CI; Hua C; Combe B; Landewe R RMD Open; 2017; 3(1):e000404. PubMed ID: 28151539 [TBL] [Abstract][Full Text] [Related]
40. Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases. Bühler S; Eperon G; Ribi C; Kyburz D; van Gompel F; Visser LG; Siegrist CA; Hatz C Swiss Med Wkly; 2015; 145():w14159. PubMed ID: 26218860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]